EUVIMEDEUVIMED entdecken
Open Access

Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization

Sarah R Beattie, Taiwo Esan, Robert Zarnowski, Emily Eix, Jeniel E Nett iD, David R Andes iD, Timothy Hagen, Damian J Krysan iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.00081-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Sarah R Beattie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Candidiasis, Vascular Access Devices. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New antifungal therapies are needed for both systemic, invasive infections in addition to superficial infections of mucosal and skin surfaces as well as biofilms associated with medical devices. The resistance of biofilm and biofilm-like growth phases of fungi contributes to the poor efficacy of systemic therapies to nonsystemic infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CandidiasisVascular Access DevicesRatsAnimalsSwineAntifungal AgentsCandida albicansCandidaCandida aurisBiofilmsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Candida albicansCandida aurisantifungal agentsbiofilms

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.
  • Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
  • Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
  • Department of Microbiology/Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.

ORCID-Profile: Jeniel E Nett, David R Andes, Damian J Krysan

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • National Science Foundation

Zitieren

APA

Beattie, S. R., Esan, T., Zarnowski, R., Eix, E., Nett, J. E., Andes, D. R., Hagen, T., & Krysan, D. J. (2023). Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00081-23

Vancouver

Beattie SR, Esan T, Zarnowski R, Eix E, Nett JE, Andes DR, et al. Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00081-23

BibTeX
@article{Beattie2023,
  author = {Beattie, Sarah R and Esan, Taiwo and Zarnowski, Robert and Eix, Emily and Nett, Jeniel E and Andes, David R and Hagen, Timothy and Krysan, Damian J},
  title = {Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.00081-23}
}
Kostenlos starten →